The Morgridge Institute for Research has received a $20.6 million award from the U.S. Department of Energy's (DoE) National Nuclear Security Administration to support the development of a new process and manufacturing plant for the isotope molybdenum-99 (Mo-99).
The agreement will support Morgridge Institute and its partner, Shine Medical Technologies, in efforts to produce molybdenum-99 without using highly enriched uranium (HEU).
Shine Medical Technologies will serve as the primary subcontractor and develop an $85 million plant capable of producing Mo-99. In January, Shine Medical picked an 84-acre site south of Janesville, WI, for its production facilities.
